Menu

Plague Outbreak in Madagascar

Pneumonic plague last month claimed 10 lives in 13 days, the World Health Organization reports.

Sep 8, 2015
Karen Zusi

Y. pestis bacteria on spines in a flea’s digestive systemFLICKR, NIAIDAn outbreak of plague erupted in Madagascar last month, the World Health Organization (WHO) reported last week (September 6). Between August 17 and August 30, the country’s Ministry of Health confirmed 14 cases of pneumonic plague, including 10 deaths.

The outbreak originated in a rural township in the Moramanga district, on the eastern half of the island nation. Plague is caused by the Yersinia pestis bacteria, which are typically spread via flea bites. The disease primarily affects rodents, but humans bitten by an infected flea can also become infected. Madagascar, Peru, and the Democratic Republic of Congo are three countries where plague remains endemic, according to the WHO.

Among forms of the disease, pneumonic plague is particularly fatal; patients can die within 24 hours of contracting the pathogen. Y. pestis-infected droplets, coughed up from infected lungs, enable human-to-human transmission. If patients are diagnosed in time, antibiotics can be effective in fighting the infection during a brief window of time following symptom manifestation.

According to the WHO, health officials in Madagascar organized a national task force to contain the August outbreak—employing active case monitoring and contact tracing, preventative antibiotic administration, and increased local communication, among other epidemic-management strategies. The country has not reported any additional cases since August 27.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.